Relapsed/Refractory Multiple Myeloma Webinar – East Coast

This high-impact, 90-minute educational program will focus on the latest evidence for optimizing treatments for RRMM patients including treating early relapse and late relapse with high risk patients. Key concepts will be covered in presentations by senior faculty, along with practice-relevant case-based discussions.